Chayakulkeeree M.Tan B.H.Chen Y.C.Patel A.Li R.Chindamporn A.Chua M.Jabeen K.Lan N.P.H.Low L.L.Sun P.L.Wahyuningsih R.Zhu L.P.Chakrabarti A.Mahidol University2025-12-112025-12-112025-12-01Medical Mycology Vol.63 No.12 (2025)https://repository.li.mahidol.ac.th/handle/123456789/113458Mould pneumonia can be life-threatening, and its incidence is increasing in Asia. Due to significant variability in diagnostic setups and the availability of antifungal agents, especially in resource-limited settings, the current treatment practices and recommendations for local clinicians are poorly described. This study aimed to develop a consensus statement on the clinical management of mould pneumonia in Asia, particularly within resource-limited settings. Clinicians and infectious disease experts from the Asia Fungal Working Group answered questions about the regional epidemiology as well as diagnostic and resource-limited treatment approaches of mould pneumonia. Guided by a literature review, 22 initial questions were generated and voted upon anonymously using a Delphi-based methodology with predefined consensus criteria. The study comprised two rounds: one to generate summary statements based on the panelists' questionnaire responses, and the other to review, confirm and rate the level of agreement of the consensus statements using a five-point Likert scale. The panelists generated 21 summary statements on the epidemiology (5), diagnosis (8), and treatment (8) of mould pneumonia, 20 of which achieved ≥ 70% consensus. Through a consensus-building exercise, clinical experts from Asia developed a set of 21 consensus statements for the diagnosis and management of mould pneumonia in resource-limited settings.MedicineArticleSCOPUS10.1093/mmy/myaf1062-s2.0-1050235468831460270941251327